Skip to main content
Clinical Trials/NCT03668184
NCT03668184
Completed
Not Applicable

What Are the Predictive Factors for Preeclampsia in Oocyte Recipients? - PREROVE

Rennes University Hospital2 sites in 1 country150 target enrollmentJanuary 2, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pregnancy
Sponsor
Rennes University Hospital
Enrollment
150
Locations
2
Primary Endpoint
occurrence of pre-eclampsia
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The main goal is to determine which risk factors develop preeclampsia in this specific group of oocyte recipients.

Registry
clinicaltrials.gov
Start Date
January 2, 2018
End Date
April 27, 2018
Last Updated
3 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Rennes University Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All major patients with a pregnancy of more than 22 weeks of amenorrhea resulting from an oocyte donation in one of the study centers, having given birth between January 2010 and April 2017 and not opposed to participation in the study.

Exclusion Criteria

  • all pregnancies resulting from an oocyte donation abroad, persons of legal age subject to legal protection (safeguard of justice, guardianship, tutorship) and persons deprived of their liberty.

Outcomes

Primary Outcomes

occurrence of pre-eclampsia

Time Frame: through study completion, an average of 1 year

Study Sites (2)

Loading locations...

Similar Trials